| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1053721729 |
| P356 | DOI | 10.1007/S00415-015-8018-7 |
| P698 | PubMed publication ID | 26810717 |
| P50 | author | Fabio Giovannelli | Q97651089 |
| Filippo Sean Giorgi | Q98897056 | ||
| P2093 | author name string | Gaetano Zaccara | |
| Sara Gasparini | |||
| Valentina Franco | |||
| P2860 | cites work | Pattern of mental illness on substance abusers | Q48245974 |
| Nocebo in clinical trials for depression: a meta-analysis | Q48402976 | ||
| Understanding the Hawthorne effect | Q50794924 | ||
| Fatigue in substance abuse disorders | Q52307225 | ||
| Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial | Q53359179 | ||
| Adverse effects of antiepileptic drugs | Q55899120 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| Why do we love medicines so much? An evolutionary perspective on the human love of pills, potions and placebo | Q28749741 | ||
| Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data | Q30955211 | ||
| Biological, clinical, and ethical advances of placebo effects | Q33703954 | ||
| Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta‐analysis | Q34311226 | ||
| Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions. | Q34359440 | ||
| High prevalence of headaches in patients with epilepsy | Q34506938 | ||
| Nocebo phenomena in medicine: their relevance in everyday clinical practice | Q36108284 | ||
| Overtreatment in epilepsy: how it occurs and how it can be avoided | Q36305771 | ||
| Highlights from the 2013 Science of Placebo thematic workshop | Q37141569 | ||
| A systematic review of adverse events in placebo groups of anti-migraine clinical trials | Q37603565 | ||
| The placebo response in clinical trials: more questions than answers | Q37876002 | ||
| Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review. | Q38219326 | ||
| Placebo and nocebo responses in drug trials of epilepsy | Q38363740 | ||
| Commission on Outcome Measurement in Epilepsy, 1994–1997: Final Report | Q41759907 | ||
| P433 | issue | 7 | |
| P921 | main subject | nocebo | Q1332954 |
| P304 | page(s) | 1274-1279 | |
| P577 | publication date | 2016-01-25 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Analysis of nocebo effects of antiepileptic drugs across different conditions | |
| P478 | volume | 263 |
| Q61799209 | Adverse events and nocebo phenomena: treatment or disease specific? |
| Q90719786 | Exploring generic brittleness and the demographic factors for its susceptibility in patients with epilepsy |
| Q44863430 | Minimizing nocebo effect: Pragmatic approach |
| Q38902279 | Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to go. |
| Q39220757 | Tolerability of new antiepileptic drugs: a network meta-analysis |
Search more.